■Business Model ・Business overview Guided by the vision of "contributing to global healthcare through microalgae technology," the company extracts DHA and other compounds from microalgae and develops them into health foods, supplements, pharmaceuticals, and more. ・Product and service features Products for the general food market have already been launched, and the company plans to accelerate its product rollout going forward. ・Customer and client features DHA and other compounds are extracted from microalgae and sold as algal biomass or extracted oil to food and supplement manufacturers, amo…

Deal details

Annual operating profit: --〜--
Assets: --〜--
Liabilities: --〜--
Net assets: --〜--
Assets to be transferred: 会社譲渡
Number of Employees
Reason for sale: その他
Reason for sale (details): 資本獲得による事業拡大、ファンド運用期間終了のため、取引条件については柔軟な対応が可能です。
Products and services: ■希望売却価格 5億円 ※取引条件については柔軟な対応が可能です。 ■売却形式株式譲渡 ■売却理由資本獲得による事業拡大 ■財務情報・売上高：0円〜1,000万円・営業利益：▲1,000万円未満 ※役員報酬1,000万円〜2,000万円、金融借入金なし
Strengths and weaknesses
Additional information